-
Je něco špatně v tomto záznamu ?
The use of combined remote electronic monitoring and blood concentrations of antipsychotics for assessment of therapeutic adherence in patients with schizophrenia: results of a prospective study
P. Šilhán, M. Hýža, S. Ambroš, P. Dostálek, J. Schwarzová, T. Skřont, D. Perničková, P. Baarová, M. Augustynek, I. Kacířová, R. Uřinovská
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
BioMedCentral
od 2001-12-01
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-06-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
Psychology Database (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- adherence k farmakoterapii * psychologie MeSH
- antipsychotika * krev terapeutické užití MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- monitorování léčiv * metody MeSH
- prospektivní studie MeSH
- schizofrenie * farmakoterapie krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Schizophrenia is a serious mental illness, the pharmacological treatment of which comprises primarily the use of antipsychotics. However, non-adherence to their use and its reliable determination present a serious clinical and economic problem. This study aimed to determine therapeutic adherence in outpatients with schizophrenia spectrum disorders by combining short-term electronic monitoring of dispenser opening with the measurement of antipsychotic blood concentrations. METHODS: A total of 55 patients underwent a week-long electronic monitoring of dispenser opening and measurement of blood concentrations before and after monitoring. Patients who correctly opened the dispenser at least in 80% of scheduled time points during the weekly interval and, at the same time, did not show a change in blood concentration of the antipsychotic by more than 30% in any direction, were considered adherent. RESULTS: 69.1% of the patients met the adherence criteria, which was less than that determined by the Drug Attitude Inventory (DAI-10), the Visual Analogue Scale (VAS), and the Clinician Rating Scale (CRS). 7.3% of the patients took less than 80% of the prescribed doses and a change in blood concentrations of the antipsychotic by more than 30% was detected in 25.4% of the patients. In 70.9% of patients, the detected concentrations were within the recommended therapeutic reference interval. The groups of adherent and non-adherent patients did not differ statistically significantly in the severity of their illness as determined by the Clinical Global Impression (CGI), the Personal and Social Performance scale (PSP), and the Positive and Negative Syndrome Scale (PANSS). CONCLUSIONS: The combined method of evaluating adherence in schizophrenia patients confirmed the results determined by other methods. The benefits of this approach are described in the paper.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015681
- 003
- CZ-PrNML
- 005
- 20250731091151.0
- 007
- ta
- 008
- 250708s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12888-025-06981-3 $2 doi
- 035 __
- $a (PubMed)40405111
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Šilhán, Petr $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 245 14
- $a The use of combined remote electronic monitoring and blood concentrations of antipsychotics for assessment of therapeutic adherence in patients with schizophrenia: results of a prospective study / $c P. Šilhán, M. Hýža, S. Ambroš, P. Dostálek, J. Schwarzová, T. Skřont, D. Perničková, P. Baarová, M. Augustynek, I. Kacířová, R. Uřinovská
- 520 9_
- $a BACKGROUND: Schizophrenia is a serious mental illness, the pharmacological treatment of which comprises primarily the use of antipsychotics. However, non-adherence to their use and its reliable determination present a serious clinical and economic problem. This study aimed to determine therapeutic adherence in outpatients with schizophrenia spectrum disorders by combining short-term electronic monitoring of dispenser opening with the measurement of antipsychotic blood concentrations. METHODS: A total of 55 patients underwent a week-long electronic monitoring of dispenser opening and measurement of blood concentrations before and after monitoring. Patients who correctly opened the dispenser at least in 80% of scheduled time points during the weekly interval and, at the same time, did not show a change in blood concentration of the antipsychotic by more than 30% in any direction, were considered adherent. RESULTS: 69.1% of the patients met the adherence criteria, which was less than that determined by the Drug Attitude Inventory (DAI-10), the Visual Analogue Scale (VAS), and the Clinician Rating Scale (CRS). 7.3% of the patients took less than 80% of the prescribed doses and a change in blood concentrations of the antipsychotic by more than 30% was detected in 25.4% of the patients. In 70.9% of patients, the detected concentrations were within the recommended therapeutic reference interval. The groups of adherent and non-adherent patients did not differ statistically significantly in the severity of their illness as determined by the Clinical Global Impression (CGI), the Personal and Social Performance scale (PSP), and the Positive and Negative Syndrome Scale (PANSS). CONCLUSIONS: The combined method of evaluating adherence in schizophrenia patients confirmed the results determined by other methods. The benefits of this approach are described in the paper.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a schizofrenie $x farmakoterapie $x krev $7 D012559
- 650 12
- $a antipsychotika $x krev $x terapeutické užití $7 D014150
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a monitorování léčiv $x metody $7 D016903
- 650 12
- $a adherence k farmakoterapii $x psychologie $7 D055118
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hýža, Martin $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic. martin.hyza@fno.cz $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. martin.hyza@fno.cz
- 700 1_
- $a Ambroš, Samuel $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Dostálek, Petr $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Schwarzová, Jana $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Skřont, Tomáš $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic
- 700 1_
- $a Perničková, Denisa $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Baarová, Pavla $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Augustynek, Martin $u Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB-Technical University Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Kacířová, Ivana $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Institute of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Uřinovská, Romana $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Institute of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 773 0_
- $w MED00008204 $t BMC psychiatry $x 1471-244X $g Roč. 25, č. 1 (2025), s. 523
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40405111 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091146 $b ABA008
- 999 __
- $a ok $b bmc $g 2366500 $s 1252806
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 25 $c 1 $d 523 $e 20250522 $i 1471-244X $m BMC psychiatry $n BMC Psychiatry $x MED00008204
- LZP __
- $a Pubmed-20250708